1. Home
  2. BOSC vs BOLD Comparison

BOSC vs BOLD Comparison

Compare BOSC & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B.O.S. Better Online Solutions

BOSC

B.O.S. Better Online Solutions

N/A

Current Price

$4.53

Market Cap

31.4M

ML Signal

N/A

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$2.53

Market Cap

36.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOSC
BOLD
Founded
1990
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
31.4M
36.5M
IPO Year
2002
2024

Fundamental Metrics

Financial Performance
Metric
BOSC
BOLD
Price
$4.53
$2.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$8.00
$4.00
AVG Volume (30 Days)
61.3K
2.2M
Earning Date
05-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.47
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.80
$0.96
52 Week High
$6.72
$2.79

Technical Indicators

Market Signals
Indicator
BOSC
BOLD
Relative Strength Index (RSI) 58.03 83.19
Support Level $4.43 $1.08
Resistance Level $4.93 N/A
Average True Range (ATR) 0.14 0.11
MACD 0.04 0.14
Stochastic Oscillator 86.49 80.85

Price Performance

Historical Comparison
BOSC
BOLD

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of comprehensive solutions to enterprises, comprised of services, equipment, and custom-made automatic machines. The company manages its business in three reportable divisions: the Supply Chain Solutions Division, the RFID Division, and the Intelligent Robotics Division. The majority of revenue derives from Supply Chain Solutions, which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their component-supply needs. Its geographic areas are Israel, East Asia, India, America, Europe, and the rest of the world. Geographically company derives the majority of its revenue from Israel.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: